$SPHS/$GBSN: IMO prostate cancer data is coming for $SPHS in Feb 2016 (at least that's what clinicaltrials.gov has listed)... I'm holding a moderate sized position into that.
$GBSN may continue the bounce here... I did sell the majority of my 1M share position at 0.29 ish for +127K$, but holding a small 100K position from 0.237ish... looking forward to the runup into/gap up into (IMO) likely FDA approval...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.